8-K: Current report
Apr 25 16:38 ET
8-K: Current report
Apr 17 16:37 ET
ZyVersa Therapeutics | DEFA14A: Others
Mar 27 17:05 ET
ZyVersa Therapeutics | 10-K: Annual report
Mar 25 08:03 ET
ZyVersa Therapeutics | DEF 14A: Definitive information statements
Mar 19 17:29 ET
ZyVersa Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 8 17:02 ET
ZyVersa Therapeutics | 8-K: Current report
Mar 8 17:02 ET
ZyVersa Therapeutics | 8-K: Current report
Mar 1 16:36 ET
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(4.0%),Ionic Management, LLC(4.0%), etc.
Feb 14 18:13 ET
ZyVersa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 14 16:43 ET
ZyVersa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.8%),Anson Management GP LLC(9.8%), etc.
Feb 14 16:21 ET
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-L1 Capital Global Opportunities Master Fund Ltd.(0%)
Feb 9 16:06 ET
ZyVersa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INCON Co., Ltd.(3.44%)
Jan 19 00:00 ET
ZyVersa Therapeutics | 8-K: Current report
Dec 22, 2023 16:45 ET
ZyVersa Therapeutics | 8-K: Current report
Dec 11, 2023 16:30 ET
ZyVersa Therapeutics | 424B4: Prospectus
Dec 8, 2023 16:44 ET
ZyVersa Therapeutics | EFFECT: Others
Dec 7, 2023 00:15 ET
ZyVersa Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Dec 6, 2023 16:13 ET
ZyVersa Therapeutics | CORRESP: CORRESP
Dec 6, 2023 00:00 ET
ZyVersa Therapeutics | CORRESP: CORRESP
Dec 6, 2023 00:00 ET
No Data
No Data